| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |